|Bldg. 29 has long anchored the FDA presence on campus.
Owing to the Food and Drug Administration’s decision to consolidate its operations at a sprawling new campus in White Oak, FDA’s Center for Biologics Evaluation and Research (CBER) and Center for Drugs Evaluation and Research (CDER)—vestiges of which have lain at the heart of NIH’s campus for 73 years—will abandon the Bldg. 29 complex this summer.
The 29 complex consists of three buildings—all of which are interconnected—located just south of the Clinical Center: Bldg. 29, built in 1960; 29A, built in 1968; and 29B, constructed in 1994.
The NIH facilities working group has decided that Bldg. 29 will remain vacant while the Office of Research Facilities studies the cost-effectiveness of renovation. Bldg. 29A will be used as swing space to facilitate ongoing renovations of Bldg. 10. And 29B, the newest wing, will be occupied by NICHD, NIAID and NIMHD.
The exit plans have nothing to do with the discovery in July of some 327 vials of infectious agents in Bldg. 29A; those were found as part of preparations to move out.